With three FDA-approved products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.
LATEST NEWS
- BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday, July 30 at 5:00 p.m. ET (23:00 CET)... MORE >
- Temporary Production Interruption at Allston Landing Manufacturing Facility Has No Impact on Aldurazyme... MORE >
- Kuvan Receives Priority Review Status From Health Canada... MORE >
-
BIOMARIN RECEIVES NORD AWARD FOR THE DEVELOPMENT OF KUVAN®
Learn more about NORD (National Organization for Rare Disorders). -
PKU (PHENYLKETONURIA)
PKU.com is a comprehensive online resource for the PKU community.